2013
Low AMH and Natural Conception
Author affiliations
- NeoFertility Clinic, Suite 7, 1st Floor, Beacon Mall, Sandyford, Dublin 18, Ireland. Phil.Boyle@NeoFertility.ie. ROR
2013
RRM Academy Synopsis
Three couples with low AMH, all advised donor-egg IVF, conceived naturally with their own eggs after cause-based treatment.
A low AMH tells you how a woman might respond to IVF stimulation. It does not tell you whether she can conceive. It is not a reason to skip treatment and route a couple straight to donor eggs. In each of these cases the AMH number was treated as a verdict, and the verdict was wrong. What changed the outcome was looking for the actual obstacles: anovulation, incomplete follicle rupture, low progesterone, poor cervical mucus, endometriosis. The working parts are ordinary restorative tools. Cause-based ovulation induction with letrozole or clomiphene, follicle tracking to confirm rupture, day-7 progesterone and oestradiol, and Creighton chart review. Natural conception needs one good egg, not the ten to twenty an IVF retrieval is built around. A thin reserve is a far smaller obstacle than the number implies. A very low AMH is a reason to look harder, not a reason to stop.
A three-couple case series from Boyle's Galway clinic, presented at the 2013 IIRRM meeting. Each case is documented end to end: serial hormone levels, Creighton charts, ultrasound follicle tracking, the exact treatment protocols, and outcomes through delivery. Each of these women had been told her own eggs were finished. Each is shown, cycle by cycle, conceiving with them.
Boyle's clinical claim has since been backed by the strongest evidence available. Steiner's 2017 JAMA cohort followed 981 women. Low AMH did not lower the chance of conceiving naturally. By twelve cycles, 84% of the low-AMH women had conceived, against 75% of those with normal AMH. The EAGeR trial (Zarek 2015) found AMH was not associated with fecundability, with conception rates near 65% across low, normal, and high AMH. Galati's 2024 study compared 252 women with unexplained infertility to 252 with male-factor infertility. Ovarian reserve markers were identical between the groups. The authors concluded ovarian reserve is unremarkable to natural conception. AMH predicts response to stimulation, an IVF parameter. It does not predict natural conception, the question these couples were actually asking. Boyle's later record carries the thread forward, including healthy singleton pregnancies after failed IVF.
AMH levels are commonly measured in fertility clinics to assess ovarian reserve and give an indication of female fertility potential. AMH levels are useful in deciding on stimulation protocols for IVF cycles. High AMH levels are useful to confirm a diagnosis of polycystic ovaries. Currently AMH levels cannot be used to predict a couple's ability to conceive naturally.
Boyle, P. C. (2013). Low AMH and Natural Conception.
Boyle PC. Low AMH and Natural Conception. 2013.